Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond
Many current chemotherapies function by damaging genomic DNA in rapidly dividing cells ultimately leading to cell death. This therapeutic approach differentially targets cancer cells that generally display rapid cell division compared to normal tissue cells. However, although these treatments are in...
Main Authors: | Davidson, David, Amrein, Lilian, Panasci, Lawrence, Aloyz, Raquel |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560216/ |
Similar Items
-
Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
by: Abu-Sanad, Atlal, et al.
Published: (2015) -
Isolation of a small molecule inhibitor of DNA base excision repair
by: Madhusudan, Srinivasan, et al.
Published: (2005) -
DNA-PK Target Identification Reveals Novel Links between DNA Repair Signaling and Cytoskeletal Regulation
by: Kotula, Ewa, et al.
Published: (2013) -
DNA glycosylases: in DNA repair and beyond
by: Jacobs, Angelika L., et al.
Published: (2011) -
A Mechanism for the Inhibition of DNA-PK-Mediated DNA Sensing by a Virus
by: Peters, Nicholas E., et al.
Published: (2013)